Evidence map›Paper›PMID 40445195›Full record

ArticleMicrobiology spectrum2025

Metagenomic sequencing of mpox virus clade Ib lesions identifies possible bacterial and viral co-infections in hospitalized patients in eastern DRC.

Leonard Schuele, Leandre Murhula Masirika, Hayley Cassidy, Philip T L C Clausen, Luca M Zaeck, Marjan Boter, Pacifique Ndishimye, Jean Claude Udahemuka, Rory D de Vries, Saria Otani and 7 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Mpox and the one health approach.Dialogues in health · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Leonard Schuele *Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0003-1721-5879
Leandre Murhula Masirika *Centre de Recherche en Sciences Naturelles de Lwiro, South-Kivu, Bukavu, Democratic Republic of the Congo.ORCID 0009-0000-0688-5688
Hayley CassidyDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0001-9087-3830
Philip T L C ClausenResearch Group for Genomic Epidemiology, National Food Institute, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-8197-7520
Luca M ZaeckDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0001-7997-493X
Marjan BoterDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0009-0003-2205-4683
Pacifique NdishimyeCongo Outbreaks, Research for Development (CORD), South-Kivu, Bukavu, Democratic Republic of the Congo.
Jean Claude UdahemukaCongo Outbreaks, Research for Development (CORD), South-Kivu, Bukavu, Democratic Republic of the Congo.
Rory D de VriesDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
Saria OtaniResearch Group for Genomic Epidemiology, National Food Institute, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-2538-8086
Richard MolenkampDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-9004-3850
David F NieuwenhuijseDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0003-1310-5031
Justin Bengehya MbiribindiCongo Outbreaks, Research for Development (CORD), South-Kivu, Bukavu, Democratic Republic of the Congo.
Freddy Belesi SiangoliCongo Outbreaks, Research for Development (CORD), South-Kivu, Bukavu, Democratic Republic of the Congo.
Marion KoopmansDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-5204-2312
Frank M Aarestrup *Research Group for Genomic Epidemiology, National Food Institute, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-7116-2723
Bas B Oude Munnink *Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-9394-1189

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mpox is an emerging zoonotic disease that caused two public health emergencies of international concern within two years. Less is known about the interplay of microbial organisms in mpox lesions which could result in superinfections that exacerbate outcomes or delay recovery. We utilized a unified metagenomic sequencing approach involving slow-speed centrifugation and differential lysis on 19 mpox lesion swabs of hospitalized patients in South Kivu province (eastern DRC) to characterize bacteria, antimicrobial resistance genes, mpox virus (MPXV), and viral co-infections. High-quality MPXV whole-genome sequences were obtained until a Ct value of 27. Furthermore, co-infections with other clinically relevant viruses, such as varicella zoster virus and herpes simplex virus-2, were detected and confirmed by real-time PCR. In addition, metagenomic sequence analysis of the bacterial content showed the presence of bacteria associated with skin and soft tissue infection in 10 of the 19 samples analyzed. These bacteria had a high abundance of resistance genes, with possible implications for antimicrobial treatment based on the predicted antimicrobial resistance. In conclusion, we report the presence of bacterial and viral pathogens in mpox lesions and detection of widespread resistance genes to the standard antibiotic treatment. The possibility of a co-infection, including antimicrobial resistance, should be considered when discussing treatment options, along with the determination of the case-fatality ratio.IMPORTANCEThe mpox virus clade Ib lineage emerged in the eastern Democratic Republic of the Congo owing to continuous human-to-human transmission in a vulnerable patient population. A major challenge of this ongoing outbreak is its occurrence in regions with severely limited healthcare infrastructure. As a result, less is known about co-infections in affected patients. Identifying and characterizing pathogens, including their antimicrobial resistance, is crucial for reducing infection-related complications and improving antimicrobial stewardship. In this study, we applied a unified metagenomics approach to detect and characterize bacterial and viral co-infections in mpox lesions of hospitalized mpox patients in the eastern DRC.

Indexed as

Bacterial InfectionsCoinfectionMonkeypox virusVirus DiseasesAdultAgedAnimalsDemocratic Republic of the CongoFemaleHospitalizationHumansMaleMetagenomicsMiddle Agedantimicrobial resistanceclade Ibco-infectionsmetagenomicsmonkeypox virusmpoxmpox virus

Identifiers

PMID40445195
PMCPMC12211058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.